Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
Submitted by
admin
on April 30, 2017 - 12:51pm
Source:
CNBC
News Tags:
Biomarin
Brineura
drug pricing
Batten disease
Headline:
BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
Do Not Allow Advertisers to Use My Personal information
